Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA-A*02 is a specific allele group within the HLA-A locus, encoding a major histocompatibility complex (MHC) class I molecule. It presents intracellular peptides to CD8+ T lymphocytes, playing a crucial role in immune surveillance. HLA-A*02 is expressed on nearly all nucleated cells and is critical for tissue compatibility testing in organ transplantation. It is also associated with susceptibility to various infectious and autoimmune diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Leukocyte Antigen Class I Histocompatibility Antigen Alpha Chain A*02 (HLA-A*02).